Order Article Reprints

Madeddu S, Ibba R, Sanna G, Piras S, Riu F, Marongiu A, Ambrosino A, Caria P, Onnis V, Franci G, et al. Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets. Pharmaceuticals. 2022; 15(2):181. https://doi.org/10.3390/ph15020181

Madeddu, Silvia, Roberta Ibba, Giuseppina Sanna, Sandra Piras, Federico Riu, Alessandra Marongiu, Annalisa Ambrosino, Paola Caria, Valentina Onnis, Gianluigi Franci, and et al. 2022. "Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets" Pharmaceuticals 15, no. 2: 181. https://doi.org/10.3390/ph15020181

Madeddu, S., Ibba, R., Sanna, G., Piras, S., Riu, F., Marongiu, A., Ambrosino, A., Caria, P., Onnis, V., Franci, G., Manzin, A., & Carta, A. (2022). Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets. Pharmaceuticals, 15(2), 181. https://doi.org/10.3390/ph15020181